FHIR Release 3 (STU)

This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3 R2

V3-VaccineManufacturer.xml

Vocabulary Work GroupMaturity Level: N/ABallot Status: Informative

Raw XML (canonical form)

The manufacturer of a vaccine.

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="v3-VaccineManufacturer"/> 
  <meta> 
    <lastUpdated value="2016-11-11T00:00:00.000+11:00"/> 
    <profile value="http://hl7.org/fhir/StructureDefinition/shareablevalueset"/> 
  </meta> 
  <text> 
    <status value="generated"/> 
    <div xmlns="http://www.w3.org/1999/xhtml">
      <p> Release Date: 2016-11-11</p> 

      <table class="grid">
 
        <tr> 
          <td> 
            <b> Level</b> 
          </td> 
          <td> 
            <b> Code</b> 
          </td> 
          <td> 
            <b> Display</b> 
          </td> 
          <td> 
            <b> Definition</b> 
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> AB
            <a name="AB"> </a> 
          </td> 
          <td> Abbott Laboratories (includes Ross Products Division)</td> 
          <td> 
                        Abbott Laboratories (includes Ross Products Division)
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> AD
            <a name="AD"> </a> 
          </td> 
          <td> Adams Laboratories</td> 
          <td> 
                        Adams Laboratories
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> ALP
            <a name="ALP"> </a> 
          </td> 
          <td> Alpha Therapeutic Corporation</td> 
          <td> 
                        Alpha Therapeutic Corporation
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> AR
            <a name="AR"> </a> 
          </td> 
          <td> Armour [Inactive - use CEN]</td> 
          <td> 
                        Armour [Inactive-use CEN]
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> AVI
            <a name="AVI"> </a> 
          </td> 
          <td> Aviron</td> 
          <td> 
                        Aviron
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> BA
            <a name="BA"> </a> 
          </td> 
          <td> Baxter Healthcare Corporation</td> 
          <td> 
                        Baxter Healthcare Corporation
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> BAY
            <a name="BAY"> </a> 
          </td> 
          <td> Bayer Corporation (includes Miles, Inc. and Cutter Laboratories)</td> 
          <td> 
                        Bayer Corporation (includes Miles, Inc. and Cutter Laboratories)
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> BP
            <a name="BP"> </a> 
          </td> 
          <td> Berna Products [Inactive - use BPC]</td> 
          <td> 
                        Berna Products [Inactive-use BPC]
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> BPC
            <a name="BPC"> </a> 
          </td> 
          <td> Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne)</td> 
          <td> 
                        Berna Products Corporation (includes Swiss Serum and Vaccine Institute
               Berne)
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> CEN
            <a name="CEN"> </a> 
          </td> 
          <td> Centeon L.L.C. (includes Armour Pharmaceutical Company)</td> 
          <td> 
                        Centeon L.L.C. (includes Armour Pharmaceutical Company)
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> CHI
            <a name="CHI"> </a> 
          </td> 
          <td> Chiron Corporation</td> 
          <td> 
                        Chiron Corporation
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> CON
            <a name="CON"> </a> 
          </td> 
          <td> Connaught [Inactive - use PMC]</td> 
          <td> 
                        Connaught [Inactive-use PMC]
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> EVN
            <a name="EVN"> </a> 
          </td> 
          <td> Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.)</td> 
          <td> 
                        Evans Medical Limited (an affiliate of Medeva Pharmaceuticals,
               Inc.)
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> GRE
            <a name="GRE"> </a> 
          </td> 
          <td> Greer Laboratories, Inc.</td> 
          <td> 
                        Greer Laboratories, Inc.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> IAG
            <a name="IAG"> </a> 
          </td> 
          <td> Immuno International AG</td> 
          <td> 
                        Immuno International AG
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> IM
            <a name="IM"> </a> 
          </td> 
          <td> Merieux [Inactive - use PMC]</td> 
          <td> 
                        Merieux [Inactive-use PMC]
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> IUS
            <a name="IUS"> </a> 
          </td> 
          <td> Immuno-U.S., Inc.</td> 
          <td> 
                        Immuno-U.S., Inc.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> JPN
            <a name="JPN"> </a> 
          </td> 
          <td> The Research Foundation for Microbial Diseases of Osaka University (BIKEN)</td> 
          <td> 
                        The Research Foundation for Microbial Diseases of Osaka University
               (BIKEN)
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> KGC
            <a name="KGC"> </a> 
          </td> 
          <td> Korea Green Cross Corporation</td> 
          <td> 
                        Korea Green Cross Corporation
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> LED
            <a name="LED"> </a> 
          </td> 
          <td> Lederle [Inactive - use WAL]</td> 
          <td> 
                        Lederle [Inactive-use WAL]
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> MA
            <a name="MA"> </a> 
          </td> 
          <td> Massachusetts Public Health Biologic Laboratories</td> 
          <td> 
                        Massachusetts Public Health Biologic Laboratories
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> MED
            <a name="MED"> </a> 
          </td> 
          <td> MedImmune, Inc.</td> 
          <td> 
                        MedImmune, Inc.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> MIL
            <a name="MIL"> </a> 
          </td> 
          <td> Miles [Inactive - use BAY]</td> 
          <td> 
                        Miles [Inactive-use BAY]
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> MIP
            <a name="MIP"> </a> 
          </td> 
          <td> Bioport Corporation (formerly Michigan Biologic Products Institute)</td> 
          <td> 
                        Bioport Corporation (formerly Michigan Biologic Products Institute)
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> MSD
            <a name="MSD"> </a> 
          </td> 
          <td> Merck and Co., Inc.</td> 
          <td> 
                        Merck &amp; Co., Inc.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> NAB
            <a name="NAB"> </a> 
          </td> 
          <td> NABI (formerly North American Biologicals, Inc.)</td> 
          <td> 
                        NABI (formerly North American Biologicals, Inc.)
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> NAV
            <a name="NAV"> </a> 
          </td> 
          <td> North American Vaccine, Inc.</td> 
          <td> 
                        North American Vaccine, Inc.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> NOV
            <a name="NOV"> </a> 
          </td> 
          <td> Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited)</td> 
          <td> 
                        Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited
               and Sandoz Limited)
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> NYB
            <a name="NYB"> </a> 
          </td> 
          <td> New York Blood Center</td> 
          <td> 
                        New York Blood Center
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> ORT
            <a name="ORT"> </a> 
          </td> 
          <td> Ortho Diagnostic Systems, Inc.</td> 
          <td> 
                        Ortho Diagnostic Systems, Inc.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> OTC
            <a name="OTC"> </a> 
          </td> 
          <td> Organon Teknika Corporation</td> 
          <td> 
                        Organon Teknika Corporation
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> PD
            <a name="PD"> </a> 
          </td> 
          <td> Parkedale Pharmaceuticals (formerly Parke-Davis)</td> 
          <td> 
                        Parkedale Pharmaceuticals (formerly Parke-Davis)
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> PMC
            <a name="PMC"> </a> 
          </td> 
          <td> Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories
               and Pasteur Merieux)</td> 
          <td> 
                        Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes
               Connaught Laboratories and Pasteur Merieux)
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> PRX
            <a name="PRX"> </a> 
          </td> 
          <td> Praxis Biologics [Inactive - use WAL]</td> 
          <td> 
                        Praxis Biologics [Inactive-use WAL]
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> SCL
            <a name="SCL"> </a> 
          </td> 
          <td> Sclavo, Inc.</td> 
          <td> 
                        Sclavo, Inc.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> SI
            <a name="SI"> </a> 
          </td> 
          <td> Swiss Serum and Vaccine Inst. [Inactive - use BPC]</td> 
          <td> 
                        Swiss Serum and Vaccine Inst. [Inactive-use BPC]
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> SKB
            <a name="SKB"> </a> 
          </td> 
          <td> SmithKline Beecham</td> 
          <td> 
                        SmithKline Beecham
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> USA
            <a name="USA"> </a> 
          </td> 
          <td> United States Army Medical Research and Materiel Command</td> 
          <td> 
                        United States Army Medical Research and Materiel Command
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> WA
            <a name="WA"> </a> 
          </td> 
          <td> Wyeth-Ayerst [Inactive - use WAL]</td> 
          <td> 
                        Wyeth-Ayerst [Inactive-use WAL]
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> WAL
            <a name="WAL"> </a> 
          </td> 
          <td> Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle
               Laboratories, and Praxis Biologics)</td> 
          <td> 
                        Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics,
               Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics)
            <br/>  

                     
          </td> 
        </tr> 

      </table> 

    </div> 
  </text> 
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status">
    <valueString value="External"/> 
  </extension> 
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
    <valueInteger value="0"/> 
  </extension> 
  <url value="http://hl7.org/fhir/ValueSet/v3-VaccineManufacturer"/> 
  <identifier> 
    <system value="urn:ietf:rfc:3986"/> 
    <value value="urn:oid:2.16.840.1.113883.1.11.227"/> 
  </identifier> 
  <version value="2016-11-11"/> 
  <name value="v3 Code System VaccineManufacturer"/> 
  <status value="active"/> 
  <experimental value="false"/> 
  <date value="2016-11-11"/> 
  <publisher value="HL7, Inc"/> 
  <contact> 
    <telecom> 
      <system value="url"/> 
      <value value="http://hl7.org"/> 
    </telecom> 
  </contact> 
  <description value=" The manufacturer of a vaccine."/> 
  <immutable value="true"/> 
  <compose> 
    <include> 
      <system value="http://hl7.org/fhir/v3/VaccineManufacturer"/> 
    </include> 
  </compose> 
</ValueSet>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.